Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ICAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ITGA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060835 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST8SIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DQB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKR1B10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1217 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100509457 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SECTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRB10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on